Peripheral Arterial Disease Trial, Recruiting (NCT04054609)

Peripheral Arterial Disease Trial, Recruiting NCT04054609 Sponsor: University Health Network, Toronto Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04054609 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have signs of severely reduced blood flow to their limbs (a condition called critical limb ischemia) and whose doctors have identified them as candidates for a procedure to restore that blood flow
Women of childbearing age who have a negative pregnancy test (either urine or blood)
People who are able to give written agreement to participate in the study

Who may not be able to join:

People for whom an MRI scan is not considered safe according to the guidelines at the treating institution
People who are unable to lie flat on their back for at least 30 minutes
People who are pregnant or currently breastfeeding
People who are unable or unwilling to give written agreement to take part
People whose doctors expect that a limb amputation will be needed within 6 weeks of entering the study
People who have metal implants or hardware in their lower limbs from a previous procedure
People who are unable to receive ethanol (confirm with trial site for details on how this applies)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick Veit-Haibach, MD, University Health Network, Toronto

Phone: 416-340-4800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04054609

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 416-340-4800

More information: https://clinicaltrials.gov/study/NCT04054609

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have signs of severely reduced blood flow to their limbs (a condition called critical limb ischemia) and whose doctors have identified them as candidates for a procedure to restore that blood flow
Women of childbearing age who have a negative pregnancy test (either urine or blood)
People who are able to give written agreement to participate in the study

Who may not be able to join:

People for whom an MRI scan is not considered safe according to the guidelines at the treating institution
People who are unable to lie flat on their back for at least 30 minutes
People who are pregnant or currently breastfeeding
People who are unable or unwilling to give written agreement to take part
People whose doctors expect that a limb amputation will be needed within 6 weeks of entering the study
People who have metal implants or hardware in their lower limbs from a previous procedure
People who are unable to receive ethanol (confirm with trial site for details on how this applies)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

31 August 2019

Est. completion

1 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Validation of FAZA PET/MRI as a biomarker of hypoxia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov